The Use of Vasopressor and Tourniquet to Reduce Hemorrhage during Myomectomy for Uterine Fibroid Removal: A Systematic Review

1 Barjon K, Mikhail LN. Uterine leiomyomata (fibroids). In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK546680 [Last accessed on 2020 Oct 16]. Search in Google Scholar

2 Williams AR. Uterine fibroids – what’s new? F1000Res. 2017;6:2109. https://doi.org/10.12688/f1000research.12172.1 PMid:29259779 Search in Google Scholar

3 Tanos V, Berry KE, Frist M, Campo R, DeWilde RL. Prevention and management of complications in laparoscopic myomectomy. Biomed Res Int. 2018;2018:8250952. https://doi.org/10.1155/2018/8250952 PMid:29693017 Search in Google Scholar

4 Fletcher H, Frederick J, Hardie M, Simeon D. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol. 1996;87(6):1014-8. https://doi.org/10.1016/0029-7844(96)00071-3 PMid:8649682 Search in Google Scholar

5 Frederick J, Fletcher H, Simeon D, Mullings A, Hardie M. Intramyometrial vasopressin as a haemostatic agent during myomectomy. Br Int J Obstet Gynaecol. 1994;101(5):435-7. https://doi.org/10.1111/j.1471-0528.1994.tb11918.x PMID: 8018617 Search in Google Scholar

6 Saha MM, Khushboo, Biswas SC, Alam H, Kamilya GS, Mukhopadhyay M, et al. Assessment of blood loss in abdominal myomectomy by intramyometrial vasopressin administration versus conventional tourniquet application. J Clin Diagn Res. 2016;10(5):QC10-3. https://doi.org/10.7860/JCDR/2016/17484.7789 PMid:27437308 Search in Google Scholar

7 Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009;339:b2535. https://doi.org/10.1136/bmj.b2535 PMid:19622551 Search in Google Scholar

8 Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March 2009). Oxford: Centre for Evidence-Based Medicine (CEBM); 1998. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009 [Last accessed on 2020 Oct 17]. Search in Google Scholar

9 Ginsburg ES, Benson CB, Garfield JM, Gleason RE, Friedman AJ. The effect of operative technique and uterine size on blood loss during myomectomy: A prospective randomized study. Fertil Steril. 1993;60(6):956-62. https://doi.org/10.1016/s0015-0282(16)56392-4 PMid:8243699 Search in Google Scholar

10 Protopapas A, Giannoulis G, Chatzipapas I, Athanasiou S, Grigoriadis T, Kathopoulis N, et al. Vasopressin during laparoscopic myomectomy: Does it really extend its limits? J Minim Invasive Gynecol. 2018;26(3):441-9. https://doi.org/10.1016/j.jmig.2018.05.011 PMid:29778690 Search in Google Scholar

11 Sapmaz E, Çelik H. Comparison of the effects of the ligation of ascending branches of bilateral arteria uterina with tourniquet method on the intra-operative and post-operative hemorrhage in abdominal myomectomy cases. Eur J Obstet Gynecol Reprod Biol. 2003;111(1):74-7. https://doi.org/10.1016/s0301-2115(03)00207-0 PMid:14557016 Search in Google Scholar

12 Dillon TF. Vasopressin as a hemostatic in gynecologic surgery. Am J Obstet Gynecol. 1959;78(6):1285-91. https://doi.org/10.1016/0002-9378(59)90591-5 PMid:13816786 Search in Google Scholar

13 Cohen SL, Senapati S, Gargiulo AR, Srouji SS, Tu FF, Solnik J, et al. Dilute versus concentrated vasopressin administration during laparoscopic myomectomy: A randomised controlled trial. BJOG. 2016;124(2):262-8. https://doi.org/10.1111/1471-0528.14179 PMid:27362908 Search in Google Scholar

14 Taylor A, Sharma M, Tsirkas P, Di Spiezio Sardo A, Setchell M, Magos A. Reducing blood loss at open myomectomy using triple tourniquets: A randomised controlled trial. BJOG. 2005;112(3):340-5. https://doi.org/10.1111/j.1471-0528.2004.00430.x PMid:15713151 Search in Google Scholar

15 Kathiresan AS, Brookfield KF, Gonzalez-Quintero VH, Verma U. Vasopressin versus a combination of vasopressin and tourniquets: A comparison of blood loss in patients undergoing abdominal myomectomies. Aust N Z J Obstet Gynaecol. 2010;51(1):79-83. https://doi.org/10.1111/j.1479-828x.2010.01253.x PMid:21299514 Search in Google Scholar

16 Agida ET, Isah AD, Isah AY. Intramyometrial vasopressin for reducing blood loss at myomectomy. Ann Med Health Sci Res. 2020;10:857-64. Search in Google Scholar

17 Chilkoti G, Mohta M, Nath S, Saxena AK, Khurana P. Anaesthetic concerns with intramyometrial vasopressin during myomectomy. Ain-Shams J Anaesthesiol. 2016;9:452-4. https://doi.org/10.4103/1687-7934.189089 Search in Google Scholar

18 Sanyal U, Ghosh S, Hiremath PB, Hiremath R The role of tourniquet in myomectomy: An observational study. Int J Reprod Contracept Obstet Gynecol. 2019;8(4):1610-5. https://doi.org/10.18203/2320-1770.ijrcog20191227 Search in Google Scholar

19 Kongnyuy EJ, van den Broek N, Wiysonge CS. A systematic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids. Int J Gynecol Obstet. 2007:100(1);4-9. https://doi.org/10.1016/j.ijgo.2007.05.050 PMid:17894936 Search in Google Scholar

20 Ikechebelu JI, Eczema CO, Obiechina NJ. The use of tourniquet to reduce blood loss at myomectomy. Niger J Clin Pract. 2010;13(2):154-8. PMid:20499747 Search in Google Scholar